Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: A randomized clinical trial
<p><strong>Background</strong> Protection induced by acellular pertussis (aP) vaccines is partial and short-lived, especially in teenagers, calling for novel immunization strategies.</p> <p><strong>Methods</strong> We conducted an investigator-driven proof-o...
| Hlavní autoři: | , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Oxford University Press
2018
|